The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF).
Publication
, Conference
Biering-Sørensen, T; Minamisawa, M; Liu, J; Claggett, B; Papolos, AI; Felker, GM; McMurray, JJV; Legg, JC; Malik, FI; Honarpour, N; Kurtz, CE ...
Published in: Eur J Heart Fail
June 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
June 2021
Volume
23
Issue
6
Start / End Page
1052 / 1056
Location
England
Related Subject Headings
- Urea
- Stroke Volume
- Humans
- Heart Failure, Systolic
- Heart Failure
- Cardiovascular System & Hematology
- Cardiac Myosins
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Biering-Sørensen, T., Minamisawa, M., Liu, J., Claggett, B., Papolos, A. I., Felker, G. M., … Solomon, S. D. (2021). The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF). In Eur J Heart Fail (Vol. 23, pp. 1052–1056). England. https://doi.org/10.1002/ejhf.2181
Biering-Sørensen, Tor, Masatoshi Minamisawa, Jiankang Liu, Brian Claggett, Alexander I. Papolos, G Michael Felker, John J. V. McMurray, et al. “The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF).” In Eur J Heart Fail, 23:1052–56, 2021. https://doi.org/10.1002/ejhf.2181.
Biering-Sørensen T, Minamisawa M, Liu J, Claggett B, Papolos AI, Felker GM, et al. The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF). In: Eur J Heart Fail. 2021. p. 1052–6.
Biering-Sørensen, Tor, et al. “The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF).” Eur J Heart Fail, vol. 23, no. 6, 2021, pp. 1052–56. Pubmed, doi:10.1002/ejhf.2181.
Biering-Sørensen T, Minamisawa M, Liu J, Claggett B, Papolos AI, Felker GM, McMurray JJV, Legg JC, Malik FI, Honarpour N, Kurtz CE, Teerlink JR, Solomon SD. The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF). Eur J Heart Fail. 2021. p. 1052–1056.
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
June 2021
Volume
23
Issue
6
Start / End Page
1052 / 1056
Location
England
Related Subject Headings
- Urea
- Stroke Volume
- Humans
- Heart Failure, Systolic
- Heart Failure
- Cardiovascular System & Hematology
- Cardiac Myosins
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology